147 related articles for article (PubMed ID: 27147579)
1. PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.
Wu Y; Yao X; Zhu M; Qian H; Jiang L; Lan T; Wu M; Pang J; Chen Y
Oncotarget; 2016 Jun; 7(23):34190-200. PubMed ID: 27147579
[TBL] [Abstract][Full Text] [Related]
2. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y
Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031
[TBL] [Abstract][Full Text] [Related]
3. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L
PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900
[TBL] [Abstract][Full Text] [Related]
4. Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells.
Zhu M; Yao X; Wu M; Qian H; Wu Y; Chen Y
Mol Med Rep; 2016 Feb; 13(2):1909-13. PubMed ID: 26676300
[TBL] [Abstract][Full Text] [Related]
5. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
Jiang L; Chen Y; Li Y; Lan T; Wu M; Wang Y; Qian H
Mol Med Rep; 2014 Apr; 9(4):1405-9. PubMed ID: 24534906
[TBL] [Abstract][Full Text] [Related]
6. Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells.
Sang J; Chen Y; Jiang L; Tao Y; Wu Y; Wang Y; Li Y; Lan T; Shao G
Mol Med Rep; 2012 Nov; 6(5):1190-4. PubMed ID: 22940826
[TBL] [Abstract][Full Text] [Related]
7. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.
Wu Y; Chen Y; Qu R; Lan T; Sang J
Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247
[TBL] [Abstract][Full Text] [Related]
8. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
9. PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.
Qian H; Tao Y; Jiang L; Wang Y; Lan T; Wu M; Pang J; Appiah-Kubi K; Chen Y; Wu Y
Cell Biol Int; 2018 Apr; 42(4):435-442. PubMed ID: 29150923
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
11. Type II, but not type I, cGMP-dependent protein kinase reverses bFGF-induced proliferation and migration of U251 human glioma cells.
Cao ZH; Tao Y; Sang JR; Gu YJ; Bian XJ; Chen YC
Mol Med Rep; 2013 Apr; 7(4):1229-34. PubMed ID: 23404188
[TBL] [Abstract][Full Text] [Related]
12. Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.
Wu M; Chen Y; Jiang L; Li Y; Lan T; Wang Y; Qian H
Oncol Lett; 2013 Dec; 6(6):1723-1728. PubMed ID: 24273605
[TBL] [Abstract][Full Text] [Related]
13. Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
Ahn SY; Kim J; Kim MA; Choi J; Kim WH
Anticancer Res; 2017 Mar; 37(3):1127-1138. PubMed ID: 28314274
[TBL] [Abstract][Full Text] [Related]
14. Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells.
Jiang L; Chen Y; Sang J; Li Y; Lan T; Wang Y; Tao Y; Qian H
Biomed Rep; 2013 May; 1(3):399-404. PubMed ID: 24648957
[TBL] [Abstract][Full Text] [Related]
15. Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation.
Lan T; Pang J; Wang Z; Wang Y; Qian H; Chen Y; Wu Y
Biochem Biophys Res Commun; 2019 Oct; 518(1):14-18. PubMed ID: 31395339
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin combined with EGFR-TKIs overcomes HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via inhibition of Met/PI3k/Akt pathway.
Wu H; Fan F; Liu Z; Shen C; Wang A; Lu Y
Cancer Chemother Pharmacol; 2015 Aug; 76(2):307-15. PubMed ID: 26063323
[TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
[TBL] [Abstract][Full Text] [Related]
18. Secretory type II cGMP-dependent protein kinase blocks activation of PDGFRβ via Ser254 in gastric cancer cells.
Pang J; Li G; Qian H; Wu Y; Chen Y
Cell Biol Int; 2022 May; 46(5):747-754. PubMed ID: 35066967
[TBL] [Abstract][Full Text] [Related]
19. Met/HGF receptor activation is regulated by juxtamembrane Ser985 phosphorylation in hepatocytes.
Nakayama M; Sakai K; Yamashita A; Nakamura T; Suzuki Y; Matsumoto K
Cytokine; 2013 Jun; 62(3):446-52. PubMed ID: 23618918
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]